• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血压能降低多少?

How much can blood pressure be lowered?

作者信息

Menard J, Chatellier G, Degoulet P, Plouin P F, Corvol P

出版信息

Hypertension. 1983 Sep-Oct;5(5 Pt 2):III21-5. doi: 10.1161/01.hyp.5.5_pt_2.iii21.

DOI:10.1161/01.hyp.5.5_pt_2.iii21
PMID:6354934
Abstract

Whatever the therapeutic goal proposed for diastolic blood pressure in hypertensive patients, the actual results of treatment in various health care delivery systems throughout the world are not as good as generally assumed. In the two recent controlled therapeutic trials, 24.5% (Australian trial) and 29.9% (Hypertension Detection and Follow-up Program) of actively treated patients had diastolic blood pressure levels above 90 mm Hg. In three British hospital clinics, diastolic blood pressure was greater than 90 mm Hg in 69% of the treated patients after 6 months to 1 year of treatment. In our own clinic, the blood pressure of 947 hypertensive patients registered in the Artemis system (Paris) between 1976 to 1980 decreased after 2 years on medical treatment from 177/108 to 142/87 mm Hg. However 21.1% of the patients studied still had a diastolic blood pressure above 95 mm Hg. In the general population, the percentage of treated patients not attaining goal levels varies from 42.9% to 71%. Not only is it important to agree upon goals, but it is urgent to standardize methods for collecting and analyzing the results of antihypertensive treatments in various health care delivery systems, since high rates of therapeutic failures might be related to the physician's strategy, the patient's characteristics, the disease's particularities, and the limited efficacy and side-effects of presently available drugs.

摘要

无论为高血压患者的舒张压设定何种治疗目标,全球各类医疗保健体系中的实际治疗效果都不如普遍认为的那样理想。在最近的两项对照治疗试验中,积极治疗的患者中有24.5%(澳大利亚试验)和29.9%(高血压检测与随访项目)的舒张压水平高于90毫米汞柱。在英国的三家医院诊所,经过6个月至1年的治疗后,69%的接受治疗患者的舒张压高于90毫米汞柱。在我们自己的诊所,1976年至1980年在阿耳忒弥斯系统(巴黎)登记的947名高血压患者,经过2年药物治疗后,血压从177/108毫米汞柱降至142/87毫米汞柱。然而,所研究的患者中有21.1%的舒张压仍高于95毫米汞柱。在普通人群中,未达到目标水平的接受治疗患者的比例在42.9%至71%之间。不仅就目标达成共识很重要,而且迫切需要规范各类医疗保健体系中抗高血压治疗结果的收集和分析方法,因为高治疗失败率可能与医生的策略、患者的特征、疾病的特殊性以及当前可用药物有限的疗效和副作用有关。

相似文献

1
How much can blood pressure be lowered?血压能降低多少?
Hypertension. 1983 Sep-Oct;5(5 Pt 2):III21-5. doi: 10.1161/01.hyp.5.5_pt_2.iii21.
2
Community care compared with hospital outpatient care for hypertensive patients.高血压患者的社区护理与医院门诊护理比较。
Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):554-6. doi: 10.1136/bmj.284.6315.554.
3
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
4
Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.收缩压和舒张压的差异控制:社区中血压控制不佳的相关因素。
Hypertension. 2000 Oct;36(4):594-9. doi: 10.1161/01.hyp.36.4.594.
5
Blood-pressure control in the hypertensive population.高血压人群的血压控制
Lancet. 1997 Feb 15;349(9050):454-7. doi: 10.1016/s0140-6736(96)07099-7.
6
[On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].在实现高血压治疗目标的道路上:开放观察性项目AESCULAP(安博诺——在血压控制不佳患者中使用双重抗高血压药物组合的临床安全性和有效性)的结果
Ter Arkh. 2013;85(9):35-45.
7
Treatment of hypertension in the elderly: a time for caution?老年高血压的治疗:是时候谨慎对待了吗?
J Am Geriatr Soc. 1984 Jan;32(1):21-3. doi: 10.1111/j.1532-5415.1984.tb05146.x.
8
Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.双重α和β受体阻滞剂对原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2015 Aug 26;2015(8):CD007449. doi: 10.1002/14651858.CD007449.pub2.
9
Cochrane in context: pharmacological interventions for hypertension in children.Cochrane背景下:儿童高血压的药物干预
Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975.
10
Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.基于家庭或医生办公室血压测量的降压治疗:一项随机对照试验。
JAMA. 2004 Feb 25;291(8):955-64. doi: 10.1001/jama.291.8.955.

引用本文的文献

1
Anomalies in the dosing of diltiazem.地尔硫䓬给药异常。
Clin Cardiol. 2000 Jan;23(1):18-23. doi: 10.1002/clc.4960230105.
2
Long-term therapy with slow-release nifedipine in essential hypertension.缓释硝苯地平用于原发性高血压的长期治疗。
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:941-5. doi: 10.1007/BF02018297.
3
The J-curve. The importance of gradual reduction of blood pressure.J曲线。血压逐渐降低的重要性。
Drugs. 1992;44 Suppl 1:56-60. doi: 10.2165/00003495-199200441-00010.